Efficacy and Safety of Atorvastatin 40 mg versus Rosuvastatin 20 mg in Patients with Type 2 Diabetes Mellitus and Previous Acute Coronary Syndrome: A Randomized Clinical Trial

BACKGROUND: The purpose of this study was to compare the efficacy and safety of high-dose atorvastatin (40 mg) versus high-dose rosuvastatin (20 mg) in Egyptian patients with type 2 diabetes and previous acute coronary syndrome history. MATERIALS AND METHODS: This open-labeled prospective, randomize...

Descripció completa

Dades bibliogràfiques

Autors principals:	Abdel-Hameed Ibrahim Mohamed Ebid, Yasmine Magdy Fahim Genina, Abdul-Majeed Abdulfattah Al-Jendy, Amira Mohamed El-Sawy
Format:	Artigo
Idioma:	Inglês
Publicat:	Via Medica 2022-06-01
Col·lecció:	Clinical Diabetology
Matèries:	Acute coronary syndrome diabetes mellitus high-intensity statin therapy atorvastatin rosuvastatin
Accés en línia:	https://journals.viamedica.pl/clinical_diabetology/article/view/88638
Etiquetes:	Afegir etiqueta Sense etiquetes, Sigues el primer a etiquetar aquest registre!